Molecular Cloning and Characterization of NKT, a Gene Product Related to the Organic Cation Transporter Family That Is Almost Exclusively Expressed in the Kidney*

(Received for publication, August 8, 1996, and in revised form, January 2, 1997)

Carlos E. Lopez-Nieto Dagger , Guofeng You , Kevin T. Bush , Elvino J. G. Barros , Davio R. Beier and Sanjay K. Nigam

From the Renal and Genetics Divisions, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

We have identified a gene product (NKT) encoding an apparently novel transcript that appears to be related to the organic ion transporter family and is expressed almost exclusively in the kidney. Analysis of the deduced 546-amino acid protein sequence indicates that NKT is a unique gene product which shares a similar transmembrane domain hydropathy profile as well as transporter-specific amino acid motifs with a variety of bacterial and mammalian nutrient transporters. Nevertheless, the overall homology of NKT to two recently cloned organic ion transport proteins (NLT and OCT-1) is significantly greater; together these three gene products may represent a new subgroup of transporters. The NKT was characterized further with respect to its tissue distribution and its expression during kidney development. A 2.5-kilobase transcript was found in kidney and at much lower levels in brain, but not in a number of other tissues. Studies on the embryonic kidney indicate that the NKT transcript is developmentally regulated with significant expression beginning at mouse gestational day 18 and rising just before birth, consistent with a role in differentiated kidney function. Moreover, in situ hybridization detected specific signals in mouse renal proximal tubules. NKT was mapped by linkage disequilibrium to mouse chromosome 19, the same site to which several mouse mutations localize, including that for osteochondrodystrophy (ocd). Although initial experiments in a Xenopus oocyte expression system failed to demonstrate transport of known substrates for OCT-1, the homology to OCT-1 and other transporters, along with the proximal tubule localization, raise the possibility that this gene may play a role in organic solute transport or drug elimination by the kidney.


INTRODUCTION

The proximal tubule of the kidney is a major site of transport of small organic molecules, including glucose, amino acids, and uric acid. The proximal tubule also plays a key role in drug elimination by the kidney. Xenobiotics and their metabolites are transported mainly by the organic anion and organic cation transport systems. These two transport systems share common substrates, and many functional features (2-9), and it is likely that these transport systems may also resemble each other at the molecular level.

A complementary DNA from rat kidney (OCT-1), which has the functional characteristics of organic cation uptake in the basolateral membrane of renal proximal tubules has been recently isolated (8). At the present time, only one nucleotide sequence (NLT) with significant homology to OCT-1 has been reported (9). NLT is a transporter protein of unknown substrate(s) present in the sinusoidal (basolateral) domain of hepatocytes. Increased expression of NLT at the time of birth correlates with the maturation of enterohepatic circulation. NLT is also present in the kidney although at a lower level than in liver. Organic anions, such as bilirubin and bromosulfophthalein, have been postulated as potential substrates for NLT, although this remains to be determined.

We report here the cloning and the molecular characterization of a transcript encoding a novel protein (NKT) apparently related to the recently identified OCT-1 and NLT. The gene product is almost exclusively expressed in kidney.


MATERIALS AND METHODS

Reverse Transcription and PCR1 Amplification

We have previously reported a method to selectively represent mammalian protein-coding regions based on statistically designed primer sets (1). This method is based on the distribution frequency of nucleotide combinations (k-tuples) in certain genetic subsets, and the combined ability of primer pairs, based on these oligonucleotides, to detect genes. Total RNA was prepared from various mouse tissues (brain, heart, placenta, lung, liver, spleen, kidney, and stomach) using the guanidinium thiocyanate-cesium chloride method (10). First strand cDNA was synthesized using a commercial kit (Life Technologies, Inc., Gaithersburg, MD). A 50-µl reaction containing 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 10 mM dithiothreitol, 3 mM MgCl2, 0.5 mM each dNTP, 10 µg/ml oligo(dT)12-18, 5 µg total RNA, 200 units of Moloney murine leukemia virus (reverse transcriptase) was incubated 60 min at 37 °C, followed by PCR amplification. In hot start PCR microcentrifuge tubes (Fisher Scientific, Pittsburg, PA) a 20-µl reaction mixture containing 2 µl of solution from the first reaction (the final concentration of buffer components was 50 mM KCl, 1.425 mM MgCl2), 1 µM of each primer (Life Technologies, Inc.), 12.5 µM of each dNTP, 0.5 µM [35S]dATP, and 1 unit of Taq DNA polymerase (Perkin-Elmer) was used. The reaction mixture was subjected to 35 PCR thermocycles at 94 °C for 30 s to denature, 50 °C for 30 s for annealing, and 72 °C for 30 s for extension, followed by 5 min at 72 °C. For analysis of the PCR products, the samples were electrophoresed in 6% sequencing-grade gels, DNA bands were visualized by autoradiography.

Cloning and Sequencing

Bands from these gels that were only present in the kidney were cut using a razor blade and DNA was dissolved in water and subsequently precipitated in a solution of 0.3 M sodium acetate (pH 6) and 2.5 volumes of ethanol. DNA in the pellet was reamplified using the same primer pair and PCR conditions. The amplified material was examined in a low-melting point 2% agarose gel, and a commercial kit (TA Cloning[Trade], Invitrogen, San Diego, CA) was employed to clone the PCR products. Positive clones (screened by blue-white changes) were grown in 1 ml of LB broth and plasmid DNA was isolated and then sequenced on an ABI 373A DNA fluorescent automated sequencer. Sequence homology searches were performed at the National Center for Biotechnology Information (NCBI) using the BLAST network service (11, 12).

RNA Blot Analysis

Total RNA was extracted from several mouse tissues (see above), as well as from mouse embryonic kidney from several developmental stages as has been previously described (10). Total RNA was electrophoresed on a 1% agarose/formaldehyde gel and transferred to a nylon membrane. In addition, human multiple tissue Northern blots I and II were purchased from Clontech (Palo Alto, CA). The probe used for hybridization was the 332-base pair fragment from the NKT cDNA clone originally isolated from the differential display gels. The probe was labeled with [32P] using a random oligonucleotide labeling kit (Pharmacia). The final washes were carried out at 65 °C. Blots were exposed to x-ray film with an intensifying screen for 3 days at -80 °C.

Rapid Amplification of 5'-cDNA and 3'-cDNA Ends (5'- and 3'-RACE)

Adaptor-ligated mouse kidney double-stranded cDNA ready for use as template in 5'- and 3'-RACE was purchased from Clontech. Gene-specific primers for 5'- and 3'-RACE reactions were designed based on the sequence of the 332-base pair fragment from the NKT cDNA originally obtained from the differential display gels. RACE reactions were performed using Clontech's Advantage[Trade] KlenTaq Polymerase Mix, 0.5 ng of template, 50 µM of each dNTP, 0.2 µM of the adapter primer (API), and 0.2 µM of either the 5' or 3' gene-specific primer (5'- and 3'-RACE respectively). The PCR products obtained were cloned and sequenced as has been previously described.

In Situ Hybridization

Mouse kidney was collected, rinsed in phosphate-buffered saline, and then fixed in ice-cold freshly prepared 4% paraformaldehyde/phosphate-buffered saline for 1 h. They were then rinsed in 0.9% NaCl and dehydrated through a graded series of ethanol and embedded in paraffin. 7-µm sections were cut, mounted on slides, dewaxed, pretreated, and prehybridized as described in Wedden et al. (13). Antisense RNA probes labeled with [alpha -35S]UTP (Amersham) were produced with T7 RNA polymerase and HindIII-linearized PCR II-NKT. Hybridization was done overnight at 50 °C. Post-hybridization treatments were as follows: (i) two washes in 50% formamide, 2 × SSC, 20 mM mercaptoethanol (FSM) at 60 °C for 30 min, (ii) digestion with 10 µg/ml RNase A in 4 × SSC, 20 mM Tris-HCl (pH 7.6), 1 mM EDTA at 37 °C for 30 min, and (iii) two washes in FSM at 60 °C for 45 min. Slides were dipped in Kodak NTB-2 emulsion and exposed for 10 days. Slides were then stained in 5 µg/ml Hoechst 33258 dye in water for 2 min, followed by rinsing 2 min in water. The slides were viewed under epifluorescence optics.

Chromosomal Localization

Primers were designed to amplify a region corresponding to the 3'-untranslated region of NKT in order to test for single strand conformation polymorphisms (SSCPs) between mouse strains. These were analyzed as described previously (14). Briefly, oligonucleotides were radiolabeled with [32P]ATP using polynucleotide kinase and genomic DNAs from a series of mouse strains were amplified using standard protocols (anneal at 55 °C for 1 min, extend at 72 °C for 2 min, and denature at 94 °C for 1 min for 40 cycles, with a final extension at 72 °C). 2 µl of the amplified reaction was added to 8.5 ml of U. S. Biochemical Corp. stop solution, denatured at 94 °C for 5 min, and immediately placed onto ice. 2 µl of each reaction was loaded on a 6% nondenaturing acrylamide sequencing gel and electrophoresed in 0.5 × TBE buffer for 2-3 h at 40 watts in a 4 °C cold room. The primer pair with the sequences CGGAGCCTGCCATTCAGAGAAAT (forward) and CTTGCAATGTCCTGGAGGTGGAA (reverse) identified polymorphisms between C57BL/6J and Mus spretus, and was used to analyze DNA prepared from the BSS backcross (15) (Fig. 7). The strain distribution pattern was analyzed using the Map Manager Program (16).


Fig. 7. A, SSCP analysis of C57BL/6J (B), M. spretus (S), and 21 progeny of the ((C57BL/6J × M. spretus)F1 × M. spretus). BSS interspecific backcross is shown. Since this is a backcross, all progeny carry an M. spretus allele, and the mice are scored for the presence or absence of a C57BL/6J allele inherited from the F1 parent. B, chromosome 19. The figure on the left is concensus map obtained from the MGD Data base at the Jackson Laboratory. Mutants (nmd, mdf, ocd, oc, Dc, and dn), genes (Gstp1 and Adrbk1), and MIT microsatellite markers are shown. The figure on right is the data obtained for the analysis of Ntk and adjacent MIT microsatellite markers in the BSS cross.
[View Larger Version of this Image (28K GIF file)]


Xenopus Oocyte Microinjection and Transport Measurement

Xenopus oocyte expression was performed as described previously (28). Manually defolliculated oocytes were injected with 40-50 ng of rat kidney medulla mRNA or NKT cRNA. Five days after injection, the uptake of radioisotope-labeled substrates was determined. For analyzing urea transport (positive control), 2.74 µCi of [14C]urea/ml and 1 mM urea were added to the uptake solution containing 200 mM mannitol, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, 5 mM Tris (pH 7.4). Uptake was stopped by washing the oocytes with ice-cold uptake solution containing unlabeled urea. Washed oocytes were dissolved in 10% SDS and radioactivity was counted in a scintillation counter. For organic anion and cation uptake, the same procedure was followed except that the uptake solution contained 100 mM NaCl, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, 5 mM Tris (pH 7.4). The uptake was stopped by washing the oocytes with ice-cold choline solution (100 mM choline, 2 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 10 mM HEPES, 5 mM Tris, pH 7.4) and the radioactivity was counted as described above.


RESULTS

Isolation of NKT cDNA

Using a new approach to selectively represent mammalian protein-coding regions (1), we identified a novel cDNA with a kidney-specific pattern of expression (Fig. 1). This clone is referred to as NKT cDNA.


Fig. 1. Portion of a sequencing grade gel showing multiple differentially expressed bands. The lanes shown correspond to total RNA from eight mouse tissues: heart (H), brain (B), placenta (P), lung (Lu), liver (Li), spleen (Sp), kidney (K), and stomach (St). These tissues were reverse transcribed and PCR amplified using the following primer pair TGTGGATGGGGTTG and GTGGTGCTG(G/C)TCAT. The top band in the kidney lane (indicated by arrow) was cloned and sequenced. The preferential expression of this band in kidney was confirmed by Northern blot.
[View Larger Version of this Image (66K GIF file)]


NKT cDNA Nucleotide and Primary Amino Acid Sequence

The NKT cDNA is 2161 nucleotides in length and contains both a consensus polyadenylation signal (AATAAA), and a nucleotide poly(A) tract defining the 3' end of the clone (Fig. 2). The open reading frame is 1638 nucleotides long and encodes a protein of 546 amino acids. The deduced primary amino acid sequence of NKT is shown in Fig. 2. The deduced amino acid sequence was separately confirmed from a cDNA clone amplified from mouse kidney mRNA. The AUG located in nucleotide position 182 has the strongest translation initiation consensus sequence according to Kozak's rules and was tentatively assigned as the first codon (17). An analysis of the primary amino acid sequence using the Kyte and Doolittle algorithm predicts 11 alpha -helical transmembrane spanning domains (18) (Fig. 3). These same domains were identified as likely transmembrane domains using the Eisenberg algorithm (19). The rather large 100-amino acid loop between putative transmembrane regions one and two is presumably located extracellularly. This loop contains four N-linked glycosylation consensus sites (Asn-X-Ser/Thr) at positions Asn-56, Asn-86, Asn-91, and Asn-107, as well as four cysteine residues Cys-49, Cys-78, Cys-99, and Cys-122 that may be involved in the formation of disulfide bridges. In addition, two hydroxyl amino acids (Ser-265 and Ser-270) located in the large intracellular loop between putative transmembrane domains six and seven represent potential targets for kinase C phosphorylation (20, 21).



Fig. 2. Nucleotide sequence and deduced amino acid sequence of the NKT cDNA.
[View Larger Versions of these Images (50 + 42K GIF file)]



Fig. 3. Kyte-Doolittle hydropathy analysis of NKT using a window setting of 21 amino acids. Hydrophobic regions corresponding to putative transmembrane spanning domains are numbered. There may be an additional potential transmembrane spanning domain between domains 2 and 3.
[View Larger Version of this Image (11K GIF file)]


Computer Searches and Conserved Motifs

Comparison of the deduced peptide sequence of this protein with those found in available data banks revealed that NKT is a novel gene product related to the family of nutrient transport proteins from eukaryotes and bacteria, including, the mammalian facilitated glucose transporters, the yeast transporters for maltose, lactose, and glucose, and the proton driven bacterial transporters for arabinose, xylose, and citrate. Computer-based homology searches of GenBank, EMBL, and SwissProt data bases indicated that our cloned cDNA has not been previously described. The data base searches indicated the NKT cDNA clone shares the greatest homology with the rat organic cation transporter (OCT-1) and a rat liver-specific transporter (NLT) of still undetermined substrate specificity. These transporters were found to be 30 and 35% identical to NKT at the amino acid level (Fig. 4). These proteins are also homologous to a group of sugar transport proteins including the human glucose transporters, the Escherichia coli xylose-proton symporter, yeast low affinity glucose transporter, and the yeast high affinity glucose transporter. Although the sugar transporter family is a fairly diverse group, members share several common structural features including, the presence of 11 transmembrane spanning domains. Also, three short sequence motifs (22) present in many transport proteins including bacterial sugar/H+ cotransporters, mammalian facilitated glucose transporters, bacterial citrate/H+ transporters, and some drug resistance proteins. All of these motifs are within the sequence of NKT clone. The first is a Gly-(Xaa3)-Asp-(Arg/Lys)Xaa-Gly-Arg(Arg/Lys) motif, which is conserved between the second and third transmembrane spanning domains. The second set of conserved motifs includes the sequences PESPRXL and PETK located after the predicted sixth and eleventh transmembrane domains, respectively. A final conserved sequence is a motif passing through transmembrane domains four and five. The conserved sequence and amino acid spacing are Arg-Xaa3-Gly-Xaa3-(Gly/Ala)-Xaa8-Pro-Xaa-Tyr-Xaa2-Glu-Xaa6-Arg-Gly-Xaa6-Gln-Xaa5-Gly. The overall sequence homology, the presence of 11 putative transmembrane domains, and the presence of the specific transporter motifs, all strongly suggest that NKT is a member of this family of proteins.


Fig. 4. Comparison of the NKT amino acid sequence with OCT-1 and NLT transport proteins. At the amino acid level, OCT-1 and NLT are 30 and 35% identical to NKT, respectively. Conserved residues are bold and underlined. All three proteins also share common structural features, including: 11 putative alpha -helical transmembrane spanning domains; a large extracellular loop between putative transmembrane regions 1 and 2; several N-linked glycosylation consensus sites and four conserved cysteine residues located in this large extracellular loop; a large intracellular loop located between putative transmembrane domains 6 and 7, with several potential target sites for protein kinase C; intracellular location of both the amino and carboxyl termini.
[View Larger Version of this Image (47K GIF file)]


Tissue Distribution and Expression of NKT mRNA

A single transcript of about 2.5 kb was observed in a mouse multiple tissue RNA blot (Fig. 5A). The transcript was most abundant in the kidney, but was also detected in very low levels in the brain. NKT transcript was not present in mouse heart, placenta, lung, liver, spleen, or stomach. In human mRNA blots, a single transcript of similar size (2.5 kb) was also observed in kidney. No signal was detected in a large number of human non-kidney tissues (Fig. 5A).


Fig. 5. Tissue distribution and developmental expression of NKT in mouse and human. In the mouse multiple tissue RNA blot (Panel A), a 2.5-kb transcript is only present in kidney (Ki), and, at much lower level, in brain (Br). No signal was detected in mouse heart (He), placenta (Pl), lung (Lu), liver (Li), spleen (Sp), or stomach (St). A single transcript of similar size (2.5 kb) was also observed in human kidney (Panel A), but no signal was detected in human brain, heart, placenta, lung, liver, skeletal muscle (Sk), pancreas (Pa), spleen, thymus (Th), prostate (Pr), testis (Te), ovary (Ov), small intestine (Sm), colon (Co), and peripheral blood leukocyte (Pb). Within the kidney (Panel B), the NKT was mainly localized to the cortex (Co) and the outer stripe (OS) of the outer medulla. RNA blot analysis of mouse kidneys at various stages of development (Panel C) shows that NKT becomes transcriptionally active close to the time of birth (fetal day 18).
[View Larger Version of this Image (45K GIF file)]


In order to determine the temporal pattern of expression of the NKT gene during kidney development, we carried out RNA blot analysis of total RNA extracted from mouse kidneys at various stages of development. As shown in Fig. 5C, NKT transcripts appeared shortly before birth (fetal day 18) and were present at relatively high levels in the adult. Apparently the NLT gene becomes transcriptionally active close to the time of birth and remains active throughout adulthood.

In situ hybridization using sense and antisense cRNA on mouse kidney paraffin sections showed that the most intense signal was present in kidney cortex, following a pattern characteristic of proximal tubular localization (Fig. 6). There was no detectable signal in the glomeruli, distal tubules, or collecting ducts. RNA blot analysis done in mouse microdissected kidney also showed an intense signal in the cortex, a moderate signal in outer stripe of the outer medulla, a faint signal in inner stripe, and no signal in inner medulla (Fig. 5B), once more consistent with a proximal tubular distribution.


Fig. 6. In situ hybridization of mouse kidney sections with antisense and sense probes of NKT cRNA. a, a parasagittal section of mouse kidney showing a strong signal for NKT probe in cortex but not in the medulla (m). Scale bar, 100 µm. b, a close-up of the cortex region shown in a. No specific signals were detected in glomeruli (arrows). Scale bar, 25 µm. c, mouse kidney hybridized with sense probe of NKT. No specific signals were detected. Scale bar, 100 µm.
[View Larger Version of this Image (107K GIF file)]


Chromosomal Localization of the NKT Gene

SSCP analysis was used to map the chromosomal localization of NKT (14, 23). Two primer pairs corresponding to non-overlapping regions of the 3'-untranslated region of NKT were analyzed and found to identify SSCPs between mouse species (see "Materials and Methods" and Fig. 7). The BSS interspecific backcross was genotyped and the strain distribution pattern, which were identical for the two primer pairs, was analyzed using the Map Manager program. NKT was found to map to chromosome 19 with a LOD likelihood score of 27.1. No recombinants were found between NKT and D19Mit32 in 94 progeny; NKT is therefore the most proximal gene mapped on chromosome 19 on the BSS cross. This is the very site to which a number of unknown murine mutations have been mapped (see "Discussion").

Evaluation of Microinjected NKT cRNA Capacity to Transport in Xenopus Oocytes

Since TEA and PAH are the prototype substrates for organic cation and organic anion transporters, respectively (8, 24), and the organic anion transporter was reported to transport PAH by exchanging with intracellular alpha -ketoglutarate (30), we examined these possibilities with NKT cRNA-injected oocytes under different conditions. The uptake of [14C]urea into rat medulla mRNA-injected oocytes was used as a positive control. Uptake of [14C]urea (1 mM) into rat medulla mRNA-injected oocytes resulted in a approx 4-fold increase above that of water control level. This is consistent with a previous study reported by You and co-workers (29). Nevertheless, NKT cRNA injected oocytes did not demonstrate a significant amount of transport of either PAH and TEA under 100 µM concentration (Fig. 8a). When the concentration of these substrates (and, in addition, cimetidine) were increased to 1 mM (Fig. 8b), still no transport was activity observed. Next, we preincubated 100 µM alpha -ketoglutarate for 30 min before the uptake of 100 µM PAH was measured (Fig. 8c); however, we were not able to show any transport activity. Our results suggest that NKT cRNA-injected oocytes do not demonstrate significant transport for the substrates tested, at least under the conditions employed here (see "Discussion").


Fig. 8. Expression of NKT in Xenopus oocytes. Filled bars represent oocytes injected with rat kidney medulla mRNA or NKT cRNA (50 ng). Open bars represent water-injected oocytes. Columns represent the mean + S.E. (n = 5-8 oocytes). a, rat kidney medulla mRNA-injected oocytes induced [14C]urea uptake (1 mM) approx 4-fold above water control level. NKT cRNA-injected oocytes did not induce significant amount of uptake of 14C-labeled PAH and TEA (100 µM). b, NKT cRNA-injected oocytes did not induce significant amount of uptake of 14C-labeled PAH, TEA, and cimetidine (1 mM, Amersham). c, NKT cRNA-injected oocytes did not induce a significant amount of uptake of 14C-labeled PAH (100 µM) with the preincubation of 100 µM alpha -ketoglutarate (a-KG) (Sigma) for 30 min.
[View Larger Version of this Image (18K GIF file)]



DISCUSSION

Renal tubular cells are responsible for the reabsorption and secretion of numerous substrates. These cells are highly polarized with unique species of transporters localized to either the basolateral or the apical domains of their plasma membranes. Using a new approach to selectively represent mammalian protein-coding regions (1), we have identified a novel transport protein which, by Northern analysis, is almost exclusively expressed in the kidney.

The sequence analyses of NKT suggest that it belongs to a recently identified subgroup of transport proteins. One member of this subgroup (OCT-1) has been shown to translocate hydrophobic and hydrophilic organic cations of different structures over the basolateral membrane of renal proximal tubules and hepatocytes (8). OCT-1 is currently considered a new prototype of polyspecific transporters likely to be important in drug elimination, although presently little is known of its specific role in various tissues. Xenobiotics and their metabolites are transported mainly by the organic anion (PAH) and organic cation transport systems, and there exist substrates that interact with both the transporter for organic anions and that for organic cations (2, 3). Neither transporter appears to detect the degree of ionization in bulk solution, and they also accept nonionizable substrates (4). Since these two transport systems (cationic and anionic) share so many common functional features, it is possible that they may also resemble each other at the molecular level. Functional expression of renal organic anion transport in Xenopus laevis oocytes injected with rat kidney poly(A)+ RNA has shown that the active species with respect to PAH transport was in the range of 1.8 to 3.5 kb (24). The size of NKT (2.5 kb) is within this range. Deduced amino acid sequence analysis showed that four cysteine residues are conserved among NKT, NLT, and OCT-1. Previous studies of the effect of N-ethylmaleimide (NEM), an irreversible sulfhydryl modifying reagent, on the transport of organic cations in the renal basolateral membrane imply that inactivation involves the binding of at least four molecules of N-ethylmaleimide per active transport unit. This is most consistent with the presence of four sulfhydryl groups at this site. The capability of organic cations to alter the susceptibility to sulfhydryl modification suggests that these groups may have a dynamic role in the transport process (25). For these and other reasons already discussed, NKT was considered to be a strong candidate for the important task of drug elimination by the kidney, a major function of the organ.

PAH and TEA are the prototype substrates of organic cation and organic anion transporters. Therefore, we tested these possibilities by measuring the uptake of the radiolabeled PAH, TEA as well as cimetidine into Xenopus oocytes. However, under the conditions we employed (including measurements in the presence of alpha -ketoglutarate (30)), we were unable to show any transport activity. At present it is unclear whether this negative result was due to suboptimal conditions for NKT transport (despite robust transport in the positive control), poor expression or insertion of an inactive (incompletely processed) transporter protein, or because NKT might transport other substrates than those we have examined so far. Expression of NKT protein in other mammalian cells such as COS-7 cells may be required to answer these questions.

Assuming NKT is a transporter, the forementioned data raises the possibility that it may have significantly different substrates from OCT-1. The low overall homology of the NKT sequence to the hexose transporters argues against its participation in sugar transport. When considering possible substrates for NKT, it is of importance to keep in mind that the expression of NKT appears to be kidney-specific, or at least relatively so. Both NLT and OCT-1 are located within the basolateral membrane. Other less closely related members of the family of nutrient transport proteins (e.g. SV2) are expressed in intracellular organelles or the membrane of synaptosomes rather than the plasma membrane (26). The subcellular location of NKT awaits the development of antibodies to carry out indirect immunofluorescent detection of the protein in kidney sections. In situ hybridization in mouse kidney showed that NKT is expressed in proximal tubules, but not in distal tubules, collecting ducts, or glomeruli (a pattern similar to that observed for OCT1). Confirmatory evidence for proximal tubular distribution was also obtained by Northern blot analysis with positive signals obtained in cortex and outer stripe, but not inner stripe and inner medulla. But unlike OCT-1 and NLT, transcripts were also detected in brain (mouse but not human), while no signal was found in liver (NLT and OCT-1) or small intestine (OCT-1). Of special interest is that NKT is expressed preferentially in the kidney and that its expression is developmentally regulated. The NKT transcripts appear shortly before birth. Studies of gene expression during kidney development have shown that genes appearing late in kidney development or at birth represent markers for highly differentiated kidney tubular cells, and these markers are often lost during neoplastic transformation. Therefore, NKT cDNA in addition to being related to organic ion transporters represents a new molecular marker for the terminally differentiated nephron.

SSCP analysis was used to localize NKT to mouse chromosome 19, tightly linked to D19Mit32. The human homologs of genes in this region such as Gstp1 and Adrbk1 map to 11q13 (27). Since subchromosomal linkage relationships are conserved in many cases between mouse and man, this result suggests that the human homolog of NKT will be found in this region. A number of interesting mouse mutations have been mapped to the proximal portion of chromosome 19, including several that affect neurological function or development (neuromuscular degeneration (nmd), muscle deficient (mdf), Dancer (Dc), deafness (dn)) or bone development (osteochondrodystrophy (ocd), osteosclerosis (oc)). Whether NKT plays a role in these murine mutations awaits further analyses.


FOOTNOTES

*   This work was supported in part by National Institutes of Health Grant DK44503, a grant from Advance Genetics Inc., National Institute of Child Health and Human Development Grant RO1 HD29028, and National Center of Human Genomic Research Grant RO1 HG00951 (to D. R. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U52842[GenBank].


Dagger    Supported by an National Institutes of Health Individual National Research Service Award.
   This work was done during tenure as an Established Investigator of the American Heart Association. To whom correspondence should be addressed: Renal Division Brigham and Women's Hospital, 75 Francis St., Boston, MA 02115. Tel.: 617-278-0436; Fax: 617-732-6392.
1   The abbreviations used are: PCR, polymerase chain reaction; RACE, rapid amplification of cDNA ends; SSCP, single strand conformation polymorphisms; kb, kilobase(s); TEA, triethanolamine; PAH, para-amino hipporic acid.

Acknowledgments

We thank Christine Miller and Duane Hinds for expert technical assistance, and Lucy Rowe for help with data analysis.


REFERENCES

  1. López-Nieto, C. E., and Nigam, S. K. (1996) Nature Biotech. 14, 857-861 [Medline] [Order article via Infotrieve]
  2. Ullrich, K. J., Rumrich, G., David, C., and Fritzsch, G. (1993) Pflugers Arch. 425, 280-299 [Medline] [Order article via Infotrieve]
  3. Ullrich, K. J., Rumrich, G., David, C., and Fritzsch, G. (1993) Pflugers Arch. 425, 300-312 [Medline] [Order article via Infotrieve]
  4. Ullrich, K. J., and Rumrich, G. (1992) Pflugers Arch. 421, 286-288 [Medline] [Order article via Infotrieve]
  5. Ullrich, K. J., and Rumrich, G. (1993) Clin. Investig. 71, 843-848
  6. Hohage, H., Morth, D. M., Querl, I. U., and Greven, J. (1994) J. Pharmacol. Exp. Ther. 268, 897-901 [Abstract]
  7. Hohage, H., Lohr, M., Querl, I. U., and Greven, J. (1994) J. Pharmacol. Exp. Ther. 269, 659-664 [Abstract]
  8. Grundemann, D., Gorboulev, V., Gambaryan, S., Veyhl, M., and Koepsell, H. (1994) Nature 372, 549-552 [Medline] [Order article via Infotrieve]
  9. Simonson, G. D., Vincent, A. C., Roberg, K. J., Huang, Y., and Iwanij, V. (1994) J. Cell Sci. 107, 1065-1072 [Abstract/Free Full Text]
  10. Chirgwin, J., Przybyla, A., MacDonald, R., and Rutter, W. J. (1979) Biochemistry 18, 5294-5299 [Medline] [Order article via Infotrieve]
  11. Gish, W., and States, D. J. (1993) Nat. Genet. 3, 266-272 [Medline] [Order article via Infotrieve]
  12. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 03-10
  13. Wedden, S., Pang, K., and Eichele, G. (1989) Development 105, 639-650 [Abstract]
  14. Beier, D. R. (1993) Mamm. Genome 4, 627-631 [Medline] [Order article via Infotrieve]
  15. Rowe, L. B., Nadeau, J. H., Turner, R., Frankel, W. N., Letts, V. A., Eppig, J. T., Ko, M. S. H., Thurston, S. J., and Birkenmeier, E. H. (1994) Mamm. Genome 5, 253-274 [Medline] [Order article via Infotrieve]
  16. Manley, K. F. (1991) Mamm. Genome 4, 303-313
  17. Kozak, M. (1987) Nucleic Acids Res. 15, 8125-8132 [Abstract]
  18. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157, 105-132 [Medline] [Order article via Infotrieve]
  19. Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. (1984) J. Mol. Biol. 179, 125-142 [Medline] [Order article via Infotrieve]
  20. Kishimoto, A., Nishiyama, K., Nakanishi, H., Uratsuji, Y., Nomura, H., Takeyama, Y., and Nishizuka, Y. (1985) J. Biol. Chem. 260, 12492-12499 [Abstract/Free Full Text]
  21. Kennelly, P. J., and Krebs, E. G. (1991) J. Biol. Chem. 266, 15555-15558 [Free Full Text]
  22. Gingrich, J. A., Andersen, P. H., Tiberi, M., Mestikawy, S. E., Jorgensen, P. N., Fremeau, R. T., and Caron, M. G. (1992) FEBS Lett. 312, 115-122 [CrossRef][Medline] [Order article via Infotrieve]
  23. Beier, D. R., Dushkin, H., and Sussman, D. J. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9102-9106 [Abstract]
  24. Wolff, N. A., Philpot, R. M., Miller, A. S., and Pritchard, J. B. (1992) Mol. Cell. Biochem. 114, 35-41 [Medline] [Order article via Infotrieve]
  25. Zimmerman, W. B., Byun, E., McKinney, T. D., and Sokol, P. P. (1991) J. Biol. Chem. 266, 5459-5463 [Abstract/Free Full Text]
  26. Bajjalieh, S. M., Peterson, K., Shinghal, R., and Sheller, R. H. (1992) Science 257, 1271-1273 [Medline] [Order article via Infotrieve]
  27. Rochelle, J. M., Watson, M. L., Oakey, R. J., and Seldin, M. F. (1992) Genomics 14, 26-31 [Medline] [Order article via Infotrieve]
  28. You, G., Lee, W-S., Barros, E. J. G., Kanai, Y., Huo, T-L., Khawaja, S., Wells, R. G., Nigam, S. K., and Hediger, M. A. (1995) J. Biol. Chem. 270, 29365-29371 [Abstract/Free Full Text]
  29. You, G., Smith, G. P., Kanai, Y., Lee, W., Stelzner, M., and Hediger, M. (1993) Nature 365, 844-847 [CrossRef][Medline] [Order article via Infotrieve]
  30. Danzler, W. H., Evans, K. K., and Wright, S. H. (1995) J. Pharmacol. Exp. Ther. 272, 663-672 [Abstract]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.